Showing 5,845 results

Filters Content type: News, Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Finance & funding

'Early medication for HIV is cost-effective'

Editor's pick
FRANCE 24
31 October 2013
Viral load

HIV rebound linked to higher baseline level, slower suppression and low-level viraemia

News
31 October 2013
Side effects

Differing Effects of Low- and High-Fat Meals on New Raltegravir Formulation

Editor's pick
NATAP
30 October 2013
Government, leadership & policy

WHO and UNAIDS advocate for an initiative to increase access to HIV treatment in the Eastern Mediterranean/Middle East and North Africa regions

Editor's pick
World Health Organization press release
30 October 2013
New & experimental HIV treatments

Dolutegravir matches or surpasses other regimens for first-line HIV treatment

News
30 October 2013
New & experimental HIV treatments

Sangamo BioSciences Presents Clinical Data From HIV Study Demonstrating Sustained Control Of Viremia

Editor's pick
Sangamo press release
29 October 2013
Retention & linkage to care

Social problems and drug and alcohol problems common among people who develop AIDS despite long-term HIV care

News
25 October 2013
HIV testing programmes & uptake

Late testing rates declining in Europe, but largely in gay men

News
24 October 2013
New & experimental HIV treatments

ViiV Healthcare announces US regulatory submission for a single-tablet regimen combining dolutegravir with abacavir and lamivudine

Editor's pick
Viiv Healthcare
23 October 2013
New & experimental HIV treatments

Future HIV care will include both novel antiretroviral drugs and new treatment strategies

News
22 October 2013
Changing treatment

Once-daily raltegravir for 48 weeks as maintenance therapy in Paris

Editor's pick
NATAP
22 October 2013
Treatment guidelines

Brazil pioneers treatment for everyone

Editor's pick
UNAIDS
21 October 2013
Starting treatment

Dual therapy with Kaletra and 3TC works well regardless of viral load

News
20 October 2013
New & experimental HIV treatments

GSK1265744 rapidly suppresses HIV and appears safe at selected dose

News
20 October 2013
Improving HIV care

Ensuring good-quality HIV care in Europe: where can we improve?

News
19 October 2013
Starting treatment

Obesity did not increase time to undetectable viral loads

Editor's pick
Healio Infectious Diseases News
19 October 2013
New & experimental HIV treatments

HIV Dual Therapy Matches Standard Triple Cocktail

Editor's pick
MedPage Today
19 October 2013
Treatment guidelines

New EACS treatment guidelines strike balance between individual choice and public health, say writers

News
18 October 2013
New & experimental HIV treatments

CCR5 inhibitor cenicriviroc shows good activity against HIV; new formulation may reduce dropouts

News
18 October 2013
Resistance

Number of people infected with drug-resistant HIV in Europe has risen by around 35%

News
17 October 2013
New & experimental HIV treatments

MODERN Study Stopped: An NRTI-Sparing, Two-Drug Initial Regimen Disappoints Again

Editor's pick
NEJM Journal Watch
17 October 2013
The search for a cure

Elusive secret of HIV long-term immunity

Editor's pick
EurekAlert!
17 October 2013
The search for a cure

Experts debate whether HIV cure is 'hype or hope'

News
17 October 2013
Drug interactions & pharmacokinetics

Merck plans phase III study of once-daily raltegravir (Isentress)

Editor's pick
Merck press release
16 October 2013